The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013

Vaccine

Volumn 32, Issue 41, 2014, Pages 5278-5284

  Cowling, Benjamin J ^a   Chan, Kwok Hung ^a   Feng, Shuo ^a   Chan, Eunice L Y ^a   Lo, Janice Y C ^b   Peiris, J S Malik ^a   Chiu, Susan S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

Children; Effectiveness; Hospitalization; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ARTICLE; CHILD; CHILD HOSPITALIZATION; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HONG KONG; HUMAN; INFANT; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; HOSPITALIZATION; INFLUENZA, HUMAN; PRESCHOOL CHILD; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HONG KONG; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; VACCINATION;

EID: 84925883459     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.07.084     Document Type: Article

References (43)

1. Cromer D., van Hoek A.J., Jit M., Edmunds W.J., Fleming D., Miller E. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect 2014, 68:363-371.
2. Mossong J., Hens N., Jit M., Beutels P., Auranen K., Mikolajczyk R., et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5:e74.
3. Uyeki T.M. Preventing and controlling influenza with available interventions. N Engl J Med 2014, 370:789-791.
4. Center for Health Protection Scientific Committee on Vaccine Preventable Diseases Recommendation on seasonal influenza vaccine for the 2013/14 season 2013.
5. Center for Health Protection Protect your child from seasonal influenza 2013.
6. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
7. Cheng A.C., Kotsimbos T., Kelly H.A., Irving L.B., Bowler S.D., Brown S.G., et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case-control study. Vaccine 2011, 29:7320-7325.
8. Orenstein E.W., De Serres G., Haber M.J., Shay D.K., Bridges C.B., Gargiullo P., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36:623-631.
9. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31:3104-3109.
10. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44.
11. Sullivan S.G., Komadina N., Grant K., Jelley L., Papadakis G., Kelly H. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match. J Med Virol 2013.
12. Kafatos G., Pebody R., Andrews N., Durnall H., Barley M., Fleming D. Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study. Influenza Other Respir Viruses 2013, 7:1175-1180.
13. Ohmit S.E., Thompson M.G., Petrie J.G., Thaker S.N., Jackson M.L., Belongia E.A., et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014, 58:319-327.
14. Skowronski D.M., Janjua N.Z., Sabaiduc S., De Serres G., Winter A.L., Gubbay J.B., et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-12 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis 2014.
15. Chiu S.S., Lau Y.L., Chan K.H., Wong W.H., Peiris J.S. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 2002, 347:2097-2103.
16. Chiu S.S., Chan K.H., Chen H., Young B.W., Lim W., Wong W.H., et al. Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis 2009, 49:1016-1021.
17. Chiu S.S., Chan K.H., So L.Y., Chen R., Chan E.L., Peiris J.S. The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong. Vaccine 2012, 30:1895-1900.
18. Centers for Disease Control and Prevention Summary recommendations: prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - (ACIP) - United States, 2013-14 2013.
19. Chan K.H., Peiris J.S.M., Lim W., Nicholls J.M., Chiu S.S. Comparison of nasopharyngeal flocked swabs and aspirates from pediatric patients for rapid diagnosis of respiratory viruses. J Clin Virol 2008, 42:65-69.
20. Lo J.Y. Respiratory Infections during SARS Outbreak, Hong Kong, 2003. Emerg Infect Dis 2005, 11:1738-1741.
21. Chan K.H., Yam W.C., Pang C.M., Chan K.M., Lam S.Y., Lo K.F., et al. Comparison of the NucliSens easyMAG and Qiagen BioRobot 9604 nucleic acid extraction systems for detection of RNA and DNA respiratory viruses in nasopharyngeal aspirate samples. J Clin Microbiol 2008, 46:2195-2199.
22. Centers for Disease Control and Prevention CDC realtime RT-PCR (rRTPCR) protocol for detection and characterization of influenza (version 2007) CDC REF. # I-007-05 2007.
23. To K.K., Wong S.S., Li I.W., Hung I.F., Tse H., Woo P.C., et al. Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection. Postgrad Med J 2010, 86:515-521.
24. Cheng A.C., Holmes M., Irving L.B., Brown S.G., Waterer G.W., Korman T.M., et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS ONE 2013, 8:e68760.
25. Eisenberg K.W., Szilagyi P.G., Fairbrother G., Griffin M.R., Staat M., Shone L.P., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008, 122:911-919.
26. Pebody R., Andrews N., Waight P., Malkani R., McCartney C., Ellis J., et al. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine 2011, 29:2613-2618.
27. Blyth C.C., Jacoby P., Effler P.V., Kelly H., Smith D.W., Robins C., et al. Effectiveness of trivalent flu vaccine in healthy young children. Pediatrics 2014.
28. Yin J.K., Khandaker G., Rashid H., Heron L., Ridda I., Booy R. Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis. Influenza Other Respir Viruses 2011, 5:299-305.
29. Cowling B.J., Chan K.H., Fang V.J., Lau L.L.H., So H.C., Fung R.O.P., et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010, 362:2175-2184.
30. Kissling E., Valenciano M., Larrauri A., Oroszi B., Cohen J.M., Nunes B., et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013, 18. pii: 20390.
31. Castilla J., Martinez-Baz I., Martinez-Artola V., Reina G., Pozo F., Garcia Cenoz M., et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013, 18. pii: 20388.
32. Pebody R., Andrews N., McMenamin J., Durnall H., Ellis J., Thompson C.I., et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 2013, 18. pii: 20389.
33. DiazGranados C.A., Denis M., Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012, 31:49-57.
34. Skowronski D.M., De Serres G., Dickinson J., Petric M., Mak A., Fonseca K., et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009, 199:168-179.
35. Lo Y.C., Chuang J.H., Kuo H.W., Huang W.T., Hsu Y.F., Liu M.T., et al. Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season. PLoS ONE 2013, 8:e58222.
36. Janjua N.Z., Skowronski D.M., De Serres G., Dickinson J., Crowcroft N.S., Taylor M., et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis 2012, 205:1858-1868.
37. Jain V.K., Rivera L., Zaman K., Espos R.A., Sirivichayakul C., Quiambao B.P., et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med 2013, 369:2481-2491.
38. Cowling B.J., Fang V.J., Nishiura H., Chan K.H., Ng S., Ip D.K., et al. Increased risk of non-influenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis 2012, 54:1778-1783.
39. Cowling B.J., Nishiura H. Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. Epidemiology 2012, 23:930-931.
40. Sundaram M.E., McClure D.L., VanWormer J.J., Friedrich T.C., Meece J.K., Belongia E.A. Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clin Infect Dis 2013, 57:789-793.
41. Lau S.K., Yip C.C., Tsoi H.W., Lee R.A., So L.Y., Lau Y.L., et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 2007, 45:3655-3664.
42. Woo P.C., Lau S.K., Chu C.M., Chan K.H., Tsoi H.W., Huang Y., et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005, 79:884-895.
43. Wong J.Y., Wu P., Nishiura H., Goldstein E., Lau E.H., Yang L., et al. Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. Am J Epidemiol 2013, 177:834-840.